» Articles » PMID: 38903945

Cytotoxicity of Phosphoramidate, Bis-amidate and CycloSal Prodrug Metabolites Against Tumour and Normal Cells

Overview
Journal RSC Med Chem
Specialty Chemistry
Date 2024 Jun 21
PMID 38903945
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphonate and phosphate prodrugs are integral to enhancing drug permeability, but the potential toxicity of their metabolites requires careful consideration. This study evaluates the impact of widely used phosphoramidate, bis-amidate, and cycloSal phosph(on)ate prodrug metabolites on BxPC3 pancreatic cancer cells, GL261-Luc glioblastoma cells, and primary cultured mouse astrocytes. 1-Naphthol and 2-naphthol demonstrated the greatest toxicity. Notably, 2-naphthol exhibited an ED of 21 μM on BxPC3 cells, surpassing 1-naphthol with an ED of 82 μM. Real-time xCELLigence experiments revealed notable activity for both metabolites at a low concentration of 16 μM. On primary cultured mouse astrocyte cells, all prodrugs exhibited reduced viability at 128 to 256 μM after only 4 hours of exposure. A cell-type-dependent sensitivity to phosph(on)ate prodrug metabolites was evident, with normal cells showing greater susceptibility than corresponding tumour cells. The results suggest it is essential to consider the potential cytotoxicity of phosph(on)ate prodrugs in the drug design and evaluation process.

Citing Articles

The key phosphorus moieties in drug design: antimicrobials and beyond.

Voracova M, Yli-Kauhaluoma J, Kiuru P Future Med Chem. 2024; 16(23):2455-2458.

PMID: 39560019 PMC: 11622798. DOI: 10.1080/17568919.2024.2423602.

References
1.
Mehellou Y, Rattan H, Balzarini J . The ProTide Prodrug Technology: From the Concept to the Clinic. J Med Chem. 2017; 61(6):2211-2226. PMC: 7075648. DOI: 10.1021/acs.jmedchem.7b00734. View

2.
Wiemer A, Wiemer D . Prodrugs of phosphonates and phosphates: crossing the membrane barrier. Top Curr Chem. 2014; 360:115-60. PMC: 4774048. DOI: 10.1007/128_2014_561. View

3.
McGuigan C, Kelleher M, Perrone P, Mulready S, Luoni G, Daverio F . The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479). Bioorg Med Chem Lett. 2009; 19(15):4250-4. DOI: 10.1016/j.bmcl.2009.05.099. View

4.
Lentini N, Foust B, Hsiao C, Wiemer A, Wiemer D . Phosphonamidate Prodrugs of a Butyrophilin Ligand Display Plasma Stability and Potent Vγ9 Vδ2 T Cell Stimulation. J Med Chem. 2018; 61(19):8658-8669. PMC: 6703555. DOI: 10.1021/acs.jmedchem.8b00655. View

5.
Dang Q, Kasibhatla S, Jiang T, Fan K, Liu Y, Taplin F . Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors. J Med Chem. 2008; 51(14):4331-9. DOI: 10.1021/jm8001235. View